All treatment comparisons

Treatment Comparison  ·  Reviewed by Dr. Ben Soffer, DO

Lexapro vs Prozac

Two of the most-prescribed SSRIs — different half-lives, different tolerability profiles

TL;DR

  • Lexapro (escitalopram) and Prozac (fluoxetine) are both first-line SSRIs with comparable response rates of around 50-60% in major depression.
  • Prozac has the longest half-life of any SSRI (~4-6 days including its active metabolite) — easier to taper, more forgiving of missed doses.
  • Lexapro has a cleaner side-effect profile and fewer drug-drug interactions (Prozac is a strong CYP2D6 inhibitor).
  • For OCD specifically, Prozac has FDA approval and decades of use at the higher OCD doses (often 60-80mg).
  • For pediatric/adolescent depression, Prozac is the only SSRI with full FDA approval (age 8+).
  • After failing both, the next step is typically a class-switch (SNRI or NDRI) or mechanism-switch (ketamine, TMS) — not another SSRI.

Side by side

Lexapro

Escitalopram

SSRI

What it treats

Major depression, GAD, Off-label: panic, social anxiety, OCD

Mechanism

Selectively blocks serotonin reuptake at SERT. Pure S-enantiomer of citalopram — fewer off-target effects than the racemic parent compound.

Strengths

  • Cleanest side-effect profile in the SSRI class
  • Minimal CYP drug interactions
  • Once-daily dosing, no titration complexity
  • Strong evidence in generalized anxiety disorder

Limitations

  • Sexual dysfunction common (30-50%)
  • QT prolongation at higher doses (avoid >20mg in older adults)
  • Shorter half-life than Prozac (~27-32 hours)
  • Less long-term safety data than older SSRIs

Prozac

Fluoxetine

SSRI

What it treats

Major depression, OCD (FDA-approved at high doses), Bulimia, PMDD, Panic, Pediatric depression (age 8+)

Mechanism

Blocks serotonin reuptake at SERT. Active metabolite norfluoxetine extends total half-life to 4-6 days. First SSRI on market (1987) — most long-term safety data.

Strengths

  • Longest half-life of any SSRI — easiest to taper, most forgiving
  • FDA-approved for pediatric depression (age 8+)
  • Strong OCD evidence at high doses (60-80mg)
  • Most long-term safety data

Limitations

  • Strong CYP2D6 inhibitor — many drug interactions
  • Sexual dysfunction (30-50%)
  • Long half-life double-edged — slow to clear if side effects intolerable
  • Activating effect can worsen anxiety initially

Which one for your situation?

If:

First SSRI, depression primary, tolerability priority

Verdict:

Lexapro — cleaner side-effect profile, fewer interactions

If:

Primary diagnosis is OCD

Verdict:

Prozac — strongest OCD evidence, FDA-approved at OCD doses

If:

Patient is under 18

Verdict:

Prozac — only SSRI with full FDA approval for pediatric depression

If:

History of missing doses

Verdict:

Prozac — long half-life makes missed doses less consequential

If:

On multiple other medications (codeine, tramadol, antipsychotics)

Verdict:

Lexapro — fewer CYP2D6 interactions

If:

Already failed both

Verdict:

Class-switch (SNRI, NDRI) or mechanism-switch (ketamine, TMS) — not another SSRI

Where ketamine fits

After SSRI failures including Lexapro and Prozac, ketamine's NMDA/glutamate mechanism is fundamentally different — patients who haven't responded to multiple serotonin-focused drugs often respond to ketamine.

Both Lexapro and Prozac: 4-8 weeks. Sublingual ketamine: hours.

Check eligibility for ketamine therapy

5-minute screening · Reviewed by a board-certified physician · FL & NJ

Frequently asked

Is one stronger than the other?

Efficacy is comparable per Cipriani 2018 network meta-analysis. The choice is about half-life, side effects, interactions, and specific indication — not "strength."

Can I switch from one to the other?

Yes, but coordinate with your physician. Switching FROM Prozac is harder because the long half-life takes weeks to clear; switching TO Prozac is easier because the long half-life is forgiving.

How long should I try one before deciding?

Standard practice: 6-8 weeks at therapeutic dose. Some clinicians extend to 12 weeks for partial responders. Less than 6 weeks is too short to fairly evaluate either.

I've tried both — what's next?

Two SSRI failures meet criteria for treatment-resistant depression. Standard options: class-switch (SNRI like Effexor, NDRI like Wellbutrin), augmentation (lithium, atypical antipsychotic), TMS, or ketamine. Ketamine is the most mechanism-distinct option.

Can ketamine be used alongside either?

In most cases, yes. Ketamine works through NMDA/glutamate signaling — different mechanism from serotonin reuptake. No need to taper before starting ketamine.

References

  1. Cipriani A et al. 2018, Lancet. Network meta-analysis ranked escitalopram and fluoxetine in the same top efficacy tier for major depression. PMID 29477251
  2. Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT in treatment-resistant depression — 64% response vs 28% placebo, including patients who failed multiple SSRIs. PMID 23982301

Other treatment comparisons